参考文献/References:
[1] Ho VK, Reijneveld JC, Enting RH, et al. Changing inci-dence and improved survival of gliomas [J]. Eur J Cancer, 2014, 50(13): 2309-2318.
[2] Jiang MC, Ni JJ, Cui WY, et al. Emerging roles of lncRNA incancer and therapeutic opportunities [J]. Am J Cancer Res, 2019, 9(7): 1354-1366.
[3] Tan Z, Zhao J, Jiang Y. MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway [J]. Cancer Med, 2018, 7(3): 913-921.
[4] 王垒垒,赵 恺,朱 蒙,等. 敲低皮层肌动蛋白的表达下降胶质瘤细胞迁移和侵袭能力[J]. 中华神经医学杂志,2014,13(4):325-329.
[5] 王秀华,陈 庚,黄 琪,等. LncRNA在胶质瘤中的研究进展[J]. 中国实验诊断学,2019,23(9): 1647-1649.
[6] Liu X, Zhu Q, Guo Y, et al. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by tar-geting miR-338-3p/PKM2 axis [J]. Biomed Pharmacother, 2019, 117: 1-9.
[7] Du YL, Liang Y, Shi GQ, et al. LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer [J]. Exp Cell Res, 2020, 395(1): 112176.
[8] 刘 露,杨福兵,朱明建,等. LncRNA CASC2靶向miR-634表达抑制神经胶质瘤细胞的生物学行为 [J]. 中国免疫学杂志,2019,35(16): 1976-1980.
[9] López-Ochoa S, Ramírez-García M, Castro-Sierra E. Ana-lysis of chromosome 17 miRNAs and their importance in medulloblastomas [J]. Biomed Res Int, 2015, 5: 1-8.
[10] Yang B, Kuai F, Chen Z, et al. miR-634 Decreases the radioresistance of human breast cancer cells by targeting STAT3 [J]. Cancer Biother Radiopharm, 2020, 35(3): 241-248.
[11] Chang Y, Huang W, Sun Q, et al. MicroRNA-634 alters nerve apoptosis via the PI3K/Akt pathway in cerebral infarction [J]. Int J Mol Med, 2018, 42(4): 2145-2154.